Schedule IV controlled substance (US)
GPTKB entity
Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Controlled_substance_schedule
|
| gptkbp:criteria |
Accepted medical use in the United States
Low potential for abuse relative to Schedule III Limited physical or psychological dependence relative to Schedule III |
| gptkbp:example |
gptkb:lorazepam
gptkb:clonazepam gptkb:diazepam gptkb:zolpidem gptkb:carisoprodol gptkb:temazepam gptkb:tramadol phenobarbital alprazolam |
| gptkbp:hasHigherAbusePotentialThan |
gptkb:Schedule_V_controlled_substance_(US)
|
| gptkbp:hasLowerAbusePotentialThan |
gptkb:Schedule_III_controlled_substance_(US)
|
| gptkbp:legalStatus |
Prescription only
|
| gptkbp:partOf |
gptkb:Controlled_Substances_Act_(US)
|
| gptkbp:regulates |
gptkb:Drug_Enforcement_Administration
|
| gptkbp:bfsParent |
gptkb:Carisoprodol
gptkb:Temazepam |
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
Schedule IV controlled substance (US)
|